Claims for Patent: 10,159,596
✉ Email this page to a colleague
Summary for Patent: 10,159,596
| Title: | Intrauterine contraceptive device |
| Abstract: | A method for promoting contraception by placing a contraceptive device within a uterus without blocking fallopian tubes may involve advancing a distal end of a delivery device through a cervix, advancing the contraceptive device comprising an elongate shape memory member out of the distal end of the delivery device and into the uterus, and limiting inferior migration of the contraceptive device within the uterus. Inferior migration may be limited by allowing the contraceptive device to assume a shape, when subjected to pressure that tends to cause a downward migration of the device within the uterus, in which an expandable middle portion of the device is expanded to contact the inner wall of the uterus and thus limit the downward migration of the device. |
| Inventor(s): | Michael Tal, Bob Katz, Mark James DeBisschop, Peter Wilson, Oleg Shikhman |
| Assignee: | Sebela Vlc Ltd |
| Application Number: | US15/217,295 |
| Patent Claims: |
1. A contraceptive device for localized delivery of a substance in a uterus, the contraceptive device comprising: only one elongate shape memory member, comprising: a bottom loop disposed at a bottom of the contraceptive device; a middle portion extending upward from the bottom loop, the middle portion comprising a first part of the elongate member and a second part of the elongate member; at least one twist configured to act as a spring portion; a first arm extending from the first part of the middle portion, wherein the first arm comprises a first bend in a first lateral direction away from the middle portion; a second arm extending from the second part of the middle portion, wherein the second arm comprises a second bend in a second lateral direction away from the middle portion, and wherein the first arm and the second arm cross over one another at a location along the first bend and the second bend, above the at least one twist; a first tissue contact surface at a first end of the first arm; and a second tissue contact surface at a second end of the second arm; at least a first substance delivery sleeve coupled with the first arm at or near the first tissue contact surface; at least a second substance delivery sleeve coupled with the second arm at or near the second tissue contact surface; and at least a third substance delivery sleeve coupled with at least one of the bottom loop or the middle portion near the bottom loop, wherein the first, second and third substance delivery members are positioned on the elongate shape memory member at locations configured to locally deliver the substance to the uterus in an area near the fallopian tubes and an area near a cervical os. 2. The device of claim 1, wherein the at least one twist comprises three or more twists. 3. The device of claim 1, wherein the substance is selected from the group consisting of copper and other spermicidal agents. 4. The device of claim 1, wherein the substance comprises copper, and wherein the substance delivery sleeves have a total surface area of no more than about 200 square millimeters. 5. The device of claim 1, wherein the substance comprises copper, and wherein the device further comprises a hormone delivery member coupled with the elongate member. 6. The device of claim 1, wherein the substance comprises a hormone. 7. The device of claim 1, wherein the at least the first substance delivery sleeve comprises multiple sleeves, wherein the at least the second substance delivery sleeve comprises multiple sleeves, and wherein the at least the third substance delivery sleeve comprises multiple sleeves. 8. The device of claim 1, wherein the first end of the elongate shape memory member comprises a first loop, and wherein the second end of the elongate shape memory member comprises a second loop. 9. The device of claim 8, wherein at least one of the at least the first substance delivery sleeve is disposed on the first loop, and wherein at least one of the at least the second substance delivery sleeve is disposed on the second loop. 10. The device of claim 1, wherein the at least the third substance delivery sleeve comprises multiple sleeves, and wherein at least one of the multiple sleeves is coupled with each of the first part and the second part of the middle portion. 11. The device of claim 1, wherein the at least the third substance delivery sleeve comprises multiple sleeves coupled with the bottom loop. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
